Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psych Congress Network
What percentage of Americans have major depressive disorder (MDD) during the course of a year, according to the DSM-5-TR?
Psychiatry May 23rd 2023
ReachMD
Dig into the essence of diagnosing and managing bipolar depression to enrich your practice and improve patient well-being. Bipolar depression often presents an intricate diagnostic challenge due to its symptomatology, leading to delays in accurate diagnosis and frequent misdiagnoses as unipolar depression. Consequently, patients run the risk of suboptimal treatment, highlighting the need for more effective strategies in diagnosing and managing bipolar depression. Traditional therapeutic approaches, including monotherapy and adjunctive therapies, pose certain limitations. Notably, these treatments present side-effect concerns, adherence challenges, and substantial relapse rates. For optimal management of bipolar depression, healthcare providers should remain updated on the evolving landscape of newer pharmacological agents. This educational program underscores the importance of timely and accurate diagnosis of bipolar depression, covering both bipolar 1 and 2 depression. The emphasis is placed on differentiating these forms from unipolar depression, a crucial aspect for early recognition and accurate diagnosis. In terms of management, the program introduces evidence-based strategies, comparing monotherapies to adjunctive therapies. It also encourages providers to evaluate current treatment options for their clinical impact. By doing so, practitioners can ensure the development of patient-centered, evidence-based treatment plans. The successful application of these diagnostic and management strategies is expected to reduce the […]
Internal Medicine May 23rd 2023
SingleCare
Pristiq and Effexor are both selective serotonin reuptake inhibitors (SSRIs) that are used to treat major depressive disorder (MDD). They are both effective in treating MDD, but they have different side effect profiles. Pristiq is generally better tolerated than Effexor, and it is less likely to cause sexual side effects. However, Pristiq is also more expensive than Effexor. If your patients are considering taking an SSRI for MDD, it is important to talk to them about about the risks and benefits of both Pristiq and Effexor. Here is a more detailed presentation of the information: Pristiq Effexor
Psychiatry May 17th 2023
CME Institute
NEW YORK CITY | THE GLASSHOUSE CHELSEASATURDAY, JUNE 24, 2023 In a comprehensive in-person setting, psychiatrists will get current, clinically relevant, and practice-based updates. This full-day conference will feature interesting presentations conducted by renowned thought leaders in schizophrenia, postpartum depression, major depressive disorder, ADHD, and addiction. Each session will include a patient perspective to ensure professionals obtain practical, real-world understanding.
Psychiatrist.com
The authors explore the clinical and economic evidence of the benefit of rTMS and discuss the impact of restricting access to the therapy through overly aggressive prior authorization practices.
Psychiatry May 9th 2023
A study of nearly 850 patients diagnosed with MDD examined the interrelationship between response rates on several outcome domains and their association with patients’ global rating of improvement.